Company Filing History:
Years Active: 2008-2011
Title: Michelle C Callegan: Innovator in Ocular Treatment
Introduction
Michelle C Callegan is a prominent inventor based in Edmond, OK (US). She has made significant contributions to the field of ocular medicine, particularly in the treatment of various eye conditions. With a total of 2 patents, her work focuses on innovative methods to address ocular wounds and infections.
Latest Patents
Callegan's latest patents include groundbreaking methods for treating ocular conditions such as bacterial keratitis, bacterial conjunctivitis, corneal ulcers, and wounds. One of her notable inventions involves the use of native, synthetic, or recombinant CAP37, along with effective peptide portions, to treat these conditions in mammals. The CAP37 peptides, including 20-44, 23-42, 102-122, and 120-146, as well as monocysteine derivatives, can also be utilized to store, clean, sterilize, or coat contact lenses. Additionally, these innovations may be applied in media for storing mammalian corneal transplants.
Career Highlights
Callegan is affiliated with the University of Oklahoma, where she continues her research and development in ocular treatments. Her work has garnered attention for its potential to improve the quality of life for individuals suffering from serious eye conditions.
Collaborations
Some of her notable coworkers include Heloise Anne Pereira and James Chodosh, who contribute to her research efforts and innovations in the field.
Conclusion
Michelle C Callegan stands out as a key figure in ocular innovation, with her patents paving the way for advanced treatments in eye care. Her dedication to improving ocular health through innovative methods is commendable and impactful.